Applied Sterilization Technologies — Operating Income (Loss), Before Adjustments
STERIS Applied Sterilization Technologies — Operating Income (Loss), Before Adjustments increased by 1.2% to $129.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.6%, from $115.80M to $129.20M. Over 2 years (FY 2023 to FY 2025), Applied Sterilization Technologies — Operating Income (Loss), Before Adjustments shows relatively stable performance with a 4.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Provides a clearer view of operational volatility and the impact of non-recurring events on the segment's bottom line.
Detailed definition
Represents the raw operating performance of the segment before excluding non-recurring items like restructuring or impai...
Peer comparison
Commonly used in financial reporting to show 'as-reported' segment performance before special items.
ste_segment_applied_sterilization_technologies_operating_income_loss_before_adjustmentsHistorical Data
| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $107.26M | $107.26M | $107.26M | $107.26M | $109.94M | $109.94M | $109.94M | $109.94M | $117.70M | $109.90M | $115.80M | $122.18M | $136.70M | $127.70M | $129.20M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.5% | +0.0% | +0.0% | +0.0% | +7.1% | -6.6% | +5.4% | +5.5% | +11.9% | -6.6% | +1.2% |
| YoY Change | — | — | — | — | +2.5% | +2.5% | +2.5% | +2.5% | +7.1% | -0.0% | +5.3% | +11.1% | +16.1% | +16.2% | +11.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's applied sterilization technologies — operating income (loss), before adjustments?
- STERIS (STE) reported applied sterilization technologies — operating income (loss), before adjustments of $129.20M in Q4 2025.
- How has STERIS's applied sterilization technologies — operating income (loss), before adjustments changed year-over-year?
- STERIS's applied sterilization technologies — operating income (loss), before adjustments increased by 11.6% year-over-year, from $115.80M to $129.20M.
- What is the long-term trend for STERIS's applied sterilization technologies — operating income (loss), before adjustments?
- Over 2 years (2023 to 2025), STERIS's applied sterilization technologies — operating income (loss), before adjustments has grown at a 4.2% compound annual growth rate (CAGR), from $429.02M to $465.58M.
- What does applied sterilization technologies — operating income (loss), before adjustments mean?
- Operating profit before accounting for one-time or non-recurring charges.